A systematic analysis of the contribution of genetics to multimorbidity and comparisons with primary care data.
Murrin O. et al, (2025), EBioMedicine, 113
Author Correction: Five ways to enhance the diversity and quality of health data.
Quattroni P. et al, (2025), Nat Med
Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study.
Thygesen JH. et al, (2025), Lancet Digit Health, 7, e145 - e156
Hearing loss and risk of major osteoporotic fracture: a population-based cohort study in the United Kingdom.
Khalid S. et al, (2025), Arch Osteoporos, 20
Development of Attention-based Prediction Models for All-cause Mortality, Home Care Need, and Nursing Home Admission in Ageing Adults in Spain Using Longitudinal Electronic Health Record Data.
Carrasco-Ribelles LA. et al, (2025), J Med Syst, 49
Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data
Xie J. et al, (2024), eClinicalMedicine, 77
Residential relocation and changes in patterns of environmental exposures by health determinants among children and adolescents in Catalonia, Spain.
Pistillo A. et al, (2024), Environ Res, 263
Expert judgement reveals current and emerging UK climate-mortality burden.
Mitchell D. et al, (2024), Lancet Planet Health, 8, e684 - e694
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021.
Barclay NL. et al, (2024), Sci Rep, 14
Self-Supervised Machine Learning to Characterise Step Counts from Wrist-Worn Accelerometers in the UK Biobank.
Small SR. et al, (2024), Med Sci Sports Exerc
Predicting malaria outbreaks using earth observation measurements and spatiotemporal deep learning modelling: a South Asian case study from 2000 to 2017
Khalid S., (2024), The Lancet Planetary Health
Clusters of post-acute COVID-19 symptoms: a latent class analysis across 9 databases and 7 countries
Prieto-Alhambra D. et al, (2024)
Incident use of hydroxychloroquine for the treatment of rheumatoid arthritis and systemic lupus erythematosus during the COVID-19 pandemic.
Mercadé-Besora N. et al, (2024), Arthritis Care Res (Hoboken)